Boric Acid

Boric Acid

SCHEMBL3219236

N#[N+]c1ccc(OCc2ccccc2)cc1.OB(O)O.OB(O)O.OB(O)O.[O-]B(O)O

nearest known ligand 0.55

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 2/20 0.53
CYP2C19 P33261 2/20 0.53
LMNA P02545 1/20 0.53
PTGS1 P23219 1/20 0.53
SLC6A2 P23975 1/20 0.53
PTGS2 P35354 1/20 0.53
SLC6A3 Q01959 1/20 0.53
HIF1A Q16665 1/20 0.53
HDAC6 Q9UBN7 1/20 0.53
MAOB P27338 4/20 0.49
NR4A1 P22736 1/20 0.47
NR4A2 P43354 1/20 0.47
NR4A3 Q92570 1/20 0.47
GAA P10253 1/20 0.47
MAPT P10636 1/20 0.47
MAOA P21397 1/20 0.47
RAB9A P51151 1/20 0.47
SMN1; SMN2 Q16637 1/20 0.47
L3MBTL1 Q9Y468 1/20 0.47
PARP10 Q53GL7 1/20 0.45

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11073984 0.89 LMNA (0.60) CYP1A2CYP2C19LMNAPTGS1SLC6A2
SCHEMBL693363 0.83 LMNA (0.53) CYP1A2CYP2C19LMNAPTGS1SLC6A2
SCHEMBL28141267 0.83 LMNA (0.53) CYP1A2CYP2C19LMNAPTGS1SLC6A2
Acetamide SCHEMBL3217821 0.81 MAOB (0.59) CYP1A2CYP2C19LMNAPTGS1SLC6A2
Trifluoromethanesulfonic Acid SCHEMBL11066760 0.77 PTPRZ1 (0.51) CYP1A2CYP2C19LMNAPTGS1SLC6A2
SCHEMBL5370132 0.76 APP (0.46) CYP1A2CYP2C19LMNAPTGS1SLC6A2
SCHEMBL339813 0.74 LMNA (0.82) CYP1A2CYP2C19LMNAPTGS1SLC6A2
SCHEMBL27367676 0.74 LMNA (0.82) CYP1A2CYP2C19LMNAPTGS1SLC6A2
SCHEMBL6059706 0.72 CYP1A2 (0.66) CYP1A2CYP2C19LMNAPTGS1SLC6A2
SCHEMBL1373373 0.72 LMNA (0.66) CYP1A2CYP2C19LMNAPTGS1SLC6A2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20100041876-A1 PROCESS FOR PREPARING AROMATIC DIAZONIUM SALTS ZYLUM BETEILIGUNGSGESELLSCHAFT MBH & CO. PATENTE II KG (DE) 2010-02-18 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100041876-A1 PROCESS FOR PREPARING AROMATIC DIAZONIUM SALTS AHNAK, NAT1, HNMT CYP1A2 362/4885CYP2C19 315/4885LMNA 3176/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.